Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NSUN6 mRNA | decreases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of NSUN6 mRNA | increases expression | 16002434
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of NSUN6 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of NSUN6 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NSUN6 mRNA | affects cotreatment|increases expression | 17942748
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NSUN6 mRNA | affects binding|increases activity|increases expression | 19710929
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of NSUN6 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NSUN6 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.46 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.87 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.49 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.49 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.88 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.84 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.87 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.87 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
1.87 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.87 | 19059307 19221464 17242785 19155303 19084267 19142967 17440819 18629630 19288272 18425577 16873071 15668708 17049068 18815881 20005174 15565566 21152245 17893378 21138602 19189212 19410462 18351453 19011961 18855134 20390343 20544844 19487384 19289846 18821012 19103187 20859285 19189210 18984771 16202921 16273361 11161223 19244106 20135344 17261762 19115204 16818667 19200415 19066611 20065188 18997820 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.85 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.69 | 11237771 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.92 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.73 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
14.71 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.71 | 16919318 11677210 17110522 15861022 17681005 16105132 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
14.71 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 8697196 15340226 15668235 12621046 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.78 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.76 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.60 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.63 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
17.68 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
17.68 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
17.68 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.24 | 16202921 17893378 19155303 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
21.60 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
21.60 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
21.60 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
21.60 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.41 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.91 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.91 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.69 | 16221962 19772884 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.69 | 12621046 16120746 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 16959395 18606429 8697196 16354765 15340226 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.28 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.28 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.23 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.81 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.68 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.37 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.37 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.50 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.20 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.20 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.37 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.55 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.55 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.55 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.92 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.92 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.92 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.32 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.22 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.81 | 19196723 19196722 11731420 16827153 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.07 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.64 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.65 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.52 | 19196722 19200415 19189210 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
4.04 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11118676 11222880 11399792 11896295 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.24 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.27 | 16644109 18247401 12479363 15754350 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.27 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.77 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.36 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.36 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.97 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.44 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.45 | 8653321 16712894 17572228 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.68 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.87 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |